» Articles » PMID: 29619864

ATRA Attenuate Proteinuria Via Downregulation of TRPC6 in Glomerulosclerosis Rats Induced by Adriamycin

Overview
Journal Ren Fail
Publisher Informa Healthcare
Date 2018 Apr 6
PMID 29619864
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: In this research, we explored the molecular mechanism of proteinuria in glomerulosclerosis rats and the protective effects of ATRA.

Methods: This research set up three groups: SHO group, GS group, and ATRA group (15 mg/(kg d), Sigma, St. Louis, MO). The serum creatinine (Scr), urea nitrogen (BUN), and 24-h proteinuria were detected 12 weeks after administration of ATRA. The pathological and ultrastructure changes were observed under light microscope and transmission electron microscope. The protein expression of TGF-β and Col-IV in glomerulus was detected by immunohitochemistry method. The mRNA and the protein expression of glomerular TRPC6 were detected by RT-PCR and Western blot.

Results: In the rat model of GS, the expressions of TRPC6 were significantly elevated compared with the normal rat group; however, the use of ATRA down-regulated the expression of TRPC6 in the glomeruli and attenuated glomerulosclerosis and proteinuria. Scr and BUN were also improved by the treatment of ATRA.

Conclusions: Our results demonstrated that ATRA could ameliorate glomerulosclerosis and proteinuria in GS, which may be related to suppressed expression of TRPC6.

Citing Articles

A New Prospect for the Treatment of Nephrotic Syndrome Based on Network Pharmacology Analysis.

Varghese R, Majumdar A Curr Res Physiol. 2022; 5:36-47.

PMID: 35098155 PMC: 8783131. DOI: 10.1016/j.crphys.2021.12.004.


(Pro)renin receptor decoy peptide PRO20 protects against adriamycin-induced nephropathy by targeting the intrarenal renin-angiotensin system.

Luo R, Yang K, Wang F, Xu C, Yang T Am J Physiol Renal Physiol. 2020; 319(5):F930-F940.

PMID: 32865014 PMC: 7701266. DOI: 10.1152/ajprenal.00279.2020.


-254C>G SNP in the Gene Promoter Influences Its Expression via Interaction with the NF-B Subunit RELA in Steroid-Resistant Nephrotic Syndrome Children.

Kuang X, Zhou Q, Li Z, Hu Y, Kang Y, Huang W Int J Genomics. 2019; 2019:2197837.

PMID: 31281825 PMC: 6590578. DOI: 10.1155/2019/2197837.

References
1.
Ruggenenti P, Cravedi P, Remuzzi G . Mechanisms and treatment of CKD. J Am Soc Nephrol. 2012; 23(12):1917-28. DOI: 10.1681/ASN.2012040390. View

2.
Ilatovskaya D, Staruschenko A . TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases. Am J Physiol Renal Physiol. 2015; 309(5):F393-7. PMC: 4556891. DOI: 10.1152/ajprenal.00186.2015. View

3.
Heeringa S, Moller C, Du J, Yue L, Hinkes B, Chernin G . A novel TRPC6 mutation that causes childhood FSGS. PLoS One. 2009; 4(11):e7771. PMC: 2777406. DOI: 10.1371/journal.pone.0007771. View

4.
Ryningen A, Stapnes C, Paulsen K, Lassalle P, Gjertsen B, Bruserud O . In vivo biological effects of ATRA in the treatment of AML. Expert Opin Investig Drugs. 2008; 17(11):1623-33. DOI: 10.1517/13543784.17.11.1623. View

5.
Reiser J, Polu K, Moller C, Kenlan P, Altintas M, Wei C . TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet. 2005; 37(7):739-44. PMC: 1360984. DOI: 10.1038/ng1592. View